Maze Therapeutics Inc. (MAZE)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$42.88
Day's range
$45.65

MAZE Income statement / Annual

Last year (2025), Maze Therapeutics Inc.'s total revenue was $0.00, a decrease of 100.00% from the previous year. In 2025, Maze Therapeutics Inc.'s net income was -$131.12 M. See Maze Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2025 FY-2024 FY-2023 FY-2022
Period Ended 12/31/2025 12/31/2024 12/31/2023 12/31/2022
Operating Revenue $0.00 $167.50 M $0.00 $0.00
Cost of Revenue $2.40 M $0.00 $0.00 $0.00
Gross Profit -$2.40 M $167.50 M $0.00 $0.00
Gross Profit Ratio 0 1 0 0
Research and Development Expenses $108.45 M $83.50 M $73.95 M $88.19 M
General & Administrative Expenses $34.45 M $26.42 M $24.61 M $22.83 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $34.45 M $26.42 M $24.61 M $22.83 M
Other Expenses -$2.40 M $0.00 $0.00 $0.00
Operating Expenses $140.50 M $109.91 M $98.55 M $111.03 M
Cost And Expenses $142.90 M $109.91 M $98.55 M $111.03 M
Interest Income $11.78 M $4.65 M $1.97 M $2.03 M
Interest Expense $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $2.40 M $3.30 M $4.09 M $3.82 M
EBITDA -$128.72 M $56.70 M -$96.33 M -$111.12 M
EBITDA Ratio 0 0.34 0 0
Operating Income Ratio 0 0.34 0 0
Total Other Income/Expenses Net $11.78 M -$4.18 M -$1.86 M -$3.91 M
Income Before Tax -$131.12 M $53.40 M -$100.42 M -$114.94 M
Income Before Tax Ratio 0 0.32 0 0
Income Tax Expense $0.00 $1.17 M $0.00 $0.00
Net Income -$131.12 M $52.23 M -$100.42 M -$114.94 M
Net Income Ratio 0 0.31 0 0
EPS -3.05 0.0778 -2.2938 -2.6256
EPS Diluted -3.05 0.0778 -2.2938 -2.6256
Weighted Average Shares Out $42.98 M $43.80 M $43.78 M $43.78 M
Weighted Average Shares Out Diluted $42.98 M $43.80 M $43.78 M $43.78 M
Link